Form 4 Tracker
CYTOKINETICS INC
CYTK

46 insider filings · Latest: Jun 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 17, 2026Mar 18 5:46 PMSung LeeEVP, Chief Financial Officer
Sale
4,935$62.15$306.7K87,127(D)

View →

Mar 17, 2026Mar 18 5:43 PMAndrew CallosEVP, Chief Commercial Officer
Sale
8,542$62.15$530.9K71,573(D)

View →

Mar 17, 2026Mar 18 5:40 PMFady Ibraham MalikEVP Research & Development
Sale
12,033$62.15$747.9K153,902(D)

View →

Mar 17, 2026Mar 18 5:37 PMRobert I BlumDirector, President & CEO
Sale
36,601$62.15$2.3M430,330(D)

View →

Mar 18, 2026Mar 18 4:55 PMAndrew CallosEVP, Chief Commercial Officer
Sale
1,930$62.07$119.8K78,185(D)

View →

Mar 16, 2026Mar 16 5:14 PMAndrew CallosEVP, Chief Commercial Officer
Sale
1,709$61.03$104.3K46,149(D)

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2026Mar 17 4:08 PMAndrew CallosEVP, Chief Commercial Officer
Grant/Award
31,145$60.0629,480(D)

View →

Mar 15, 2026Mar 17 4:06 PMJeffrey HessekielChief Legal & Admin Officer
Grant/Award
31,145$60.0622,820(D)

View →

Mar 15, 2026Mar 17 4:05 PMSung LeeEVP, Chief Financial Officer
Grant/Award
31,145$60.0629,480(D)

View →

Mar 15, 2026Mar 17 4:03 PMFady Ibraham MalikEVP Research & Development
Grant/Award
41,192$60.0639,527(D)

View →

← Previous

Page 2 of 2